Revisiting Terminalia arjuna–an ancient cardiovascular drug S Dwivedi, D Chopra Journal of traditional and complementary medicine 4 (4), 224-231, 2014 | 147 | 2014 |
Chemotherapy-induced adverse drug reactions in oncology patients: a prospective observational survey D Chopra, H Rehan, V Sharma, R Mishra Indian Journal of Medical and Paediatric Oncology 37 (01), 42-46, 2016 | 129 | 2016 |
A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of paracetamol, serratiopeptidase, ibuprofen and betamethasone using the dental impaction … D Chopra, HS Rehan, P Mehra, AK Kakkar International journal of oral and maxillofacial surgery 38 (4), 350-355, 2009 | 117 | 2009 |
Physician's guide to pharmacovigilance: terminology and causality assessment HS Rehan, D Chopra, AK Kakkar European journal of internal medicine 20 (1), 3-8, 2009 | 116 | 2009 |
Comparison of knowledge, attitude and practices of resident doctors and nurses on adverse drug reaction monitoring and reporting in a tertiary care hospital HS Rehan, RK Sah, D Chopra Indian journal of pharmacology 44 (6), 699-703, 2012 | 77 | 2012 |
Self-directed learning: assessment of students’ abilities and their perspective B Bhandari, D Chopra, K Singh Advances in physiology education 44 (3), 383-386, 2020 | 64 | 2020 |
Knowledge, attitude and practices associated with adverse drug reaction reporting amongst doctors in a teaching hospital D Chopra, N Wardhan, HS Rehan International Journal of Risk & Safety in Medicine 23 (4), 227-232, 2011 | 63 | 2011 |
Comparative efficacy and safety of oxcarbazepine versus divalproex sodium in the treatment of acute mania: a pilot study AK Kakkar, HS Rehan, KES Unni, NK Gupta, D Chopra, D Kataria European Psychiatry 24 (3), 178-182, 2009 | 43 | 2009 |
Prevalence of self-reported anxiety and self-medication among upper and middle socioeconomic strata amidst COVID-19 pandemic D Chopra, B Bhandari, JK Sidhu, K Jakhar, F Jamil, R Gupta Journal of education and health promotion 10 (1), 2021 | 41 | 2021 |
Antimicrobial susceptibility patterns of an emerging multidrug resistant nosocomial pathogen: Acinetobacter baumannii R Tewari, D Chopra, R Wazahat, S Dhingra, M Dudeja The Malaysian journal of medical sciences: MJMS 25 (3), 129, 2018 | 39 | 2018 |
Adverse drug reactions: trends in a tertiary care hospital H S Rehan, D Chopra, R K Sah, R Mishra Current drug safety 7 (5), 384-388, 2012 | 34 | 2012 |
Injection practices of healthcare professionals in a Tertiary Care Hospital HS Rehan, D Chopra, RK Sah, T Chawla, A Agarwal, GK Sharma Journal of Infection and Public Health 5 (2), 177-181, 2012 | 30 | 2012 |
Causality assessment of spontaneously reported adverse drug events: Comparison of WHO-UMC criteria and Naranjo probability scale HS Rehan, D Chopra, AK Kakkar International Journal of Risk & Safety in Medicine 19 (4), 223-227, 2007 | 26 | 2007 |
Adverse drug reactions of anti-epileptic drugs in children with epilepsy: a cross-sectional study S Kaushik, D Chopra, S Sharma, S Aneja Current drug safety 14 (3), 217-224, 2019 | 23 | 2019 |
Diversity of genotype and mode of spread of Hepatitis C virus in Northern India HS Rehan, S Manak, M Yadav, D Chopra, N Wardhan Saudi Journal of Gastroenterology 17 (4), 241-244, 2011 | 23 | 2011 |
An observational study of cutaneous adverse drug reactions in a teaching hospital D Chopra, V Sharma, R Kapoor, S Dwivedi International journal of clinical pharmacy 37, 996-999, 2015 | 19 | 2015 |
Anaphylaxis following intravenous ranitidine: A rare adverse reaction of a common drug D Chopra, P Arora, S Khan, S Dwivedi Indian journal of pharmacology 46 (2), 234-236, 2014 | 19 | 2014 |
Pharmacological effects of Tribulus terrestris: A review B Bhandari, D Chopra, SK Kohli Int. J. Contemp. Med 1 (1), 71-75, 2013 | 15 | 2013 |
Ciclesonide-a novel corticosteroid for the management of asthma D Chopra, B Bhandari, N Wardhan Current Clinical Pharmacology 7 (2), 73-77, 2012 | 12 | 2012 |
Galactorrhoea: Report of two cases OM Patrascu, D Chopra, S Dwivedi Mædica 10 (2), 136, 2015 | 11 | 2015 |